CVS Reaches Proposed Insulin Pricing Settlement With FTC
CVS Health announced a proposed settlement with the Federal Trade Commission regarding insulin pricing on Tuesday. The agreement follows a federal inquiry.
Xurve View
Insights:
Xurve View
CVS Health Corporation announced on Tuesday that it has entered into a proposed settlement agreement with the Federal Trade Commission (FTC) regarding insulin pricing. The healthcare company, which operates extensively across the United States, reached the deal following regulatory scrutiny into the costs of the life-saving medication.
